← All organizations

Stryker

For profitWebsite ↗

Also known as: Stryker Biotech | Stryker European Operations BV | Stryker Instruments | Stryker Medical | Stryker Neurovascular | Stryker Nordic | Stryker Orthopaedics | The Orthopedic Frame Company

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2005

First marketed drug

Nov 21, 2018

Last known activity

Jan 31, 2024

Timeline

1940s

  1. Jun 1, 1941

    Stryker— Founded

1970s

  1. Jun 1, 1979

    Osteonics— Acquired

1980s

  1. Jun 1, 1981

    Synoptics— Acquired

1990s

  1. Jun 1, 1999

    Matsumoto Instruments Co.— Acquired

2000s

  1. Jun 2, 2000

    Image Guided Technologies— Acquired

  2. Jul 21, 2004

    SpineCore— Acquired

  3. Feb 23, 2005

    eTrauma.com— Acquired

  4. Dec 30, 2005

    PlasmaSol Corp.— Acquired

  5. Mar 16, 2006

    Sightline Technologies Ltd— Acquired

  6. Nov 30, 2009

    Ascent Healthcare Solutions, Inc.— Acquired

2010s

  1. May 16, 2011

    Orthovita— Acquired

  2. Jul 6, 2011

    Memometal Technologies— Acquired

  3. Aug 31, 2011

    Concentric Medical— Acquired

  4. Oct 16, 2012

    Surpass Medical— Acquired

  5. Sep 25, 2013

    MAKO Surgical— Acquired

  6. Dec 31, 2013

    Patient Safety Technologies— Acquired

  7. Feb 18, 2014

    Berchtold Holding AG— Acquired

  8. Feb 19, 2014

    Pivot Medical— Acquired

  9. Feb 21, 2014

    Trauson— Acquired

  10. Jun 30, 2014

    Small Bone Innovations— Acquired

  11. Feb 1, 2016

    Sage Products, Inc.— Acquired

  12. Feb 16, 2016

    Physio-Control— Acquired

  13. Apr 29, 2016

    Stanmore Implants Worldwide— Acquired

  14. Sep 1, 2017

    Novadaq Technologies Inc.— Acquired

  15. Oct 24, 2017

    Vexim— Acquired

  16. Dec 7, 2017

    Entellus Medical— Acquired

  17. May 1, 2018

    Hygia Health Services— Acquired

  18. Jun 25, 2018

    SafeAir— Acquired

  19. Aug 30, 2018

    K2M— Acquired

  20. Sep 11, 2018

    Invuity— Acquired

  21. Oct 1, 2018

    HyperBranch Medical Technology— Acquired

  22. Nov 21, 2018

    indocyanine green— NDA Secondary Org

  23. Feb 25, 2019

    Arrinex, Inc.— Acquired

  24. Mar 3, 2019

    OrthoSpace— Acquired

  25. Nov 4, 2019

    Wright Medical Group— Acquired

2020s

  1. Feb 23, 2022

    apomorphine— Marketing Organization

Drugs by trial phase (14 distinct, 23 trials)

Phase 4 (1 own, 1 via acquisition)

Phase 3 (2 own, 1 via acquisition)

Phase 2 (2 own, 3 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Other trials (1 own, 2 via acquisition)

Indications

Marketed drugs (2)

Subsidiaries (33 direct, 41 total across the full acquisition tree)

Recent trials (13)

Details

Founded
Kalamazoo, Michigan, US Jun 1, 1941
Last known activity
Jan 31, 2024